Neuraxis Stock Performance
| NRXS Stock | 4.86 0.23 4.97% |
On a scale of 0 to 100, Neuraxis holds a performance score of 12. The company secures a Beta (Market Risk) of 1.37, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neuraxis will likely underperform. Please check Neuraxis' sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Neuraxis' current price movements will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Neuraxis are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Neuraxis unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 78.6 K | |
| Total Cashflows From Investing Activities | -27.8 K | |
| Free Cash Flow | -6.1 M |
Neuraxis Relative Risk vs. Return Landscape
If you would invest 311.00 in Neuraxis on October 25, 2025 and sell it today you would earn a total of 175.00 from holding Neuraxis or generate 56.27% return on investment over 90 days. Neuraxis is currently generating 0.8787% in daily expected returns and assumes 5.525% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Neuraxis, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Neuraxis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuraxis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neuraxis, and traders can use it to determine the average amount a Neuraxis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Neuraxis is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuraxis by adding it to a well-diversified portfolio.
Neuraxis Fundamentals Growth
Neuraxis Stock prices reflect investors' perceptions of the future prospects and financial health of Neuraxis, and Neuraxis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neuraxis Stock performance.
| Return On Equity | -30.71 | ||||
| Return On Asset | -1.37 | ||||
| Profit Margin | (2.24) % | ||||
| Operating Margin | (2.59) % | ||||
| Current Valuation | 48.41 M | ||||
| Shares Outstanding | 9.99 M | ||||
| Price To Book | 22.93 X | ||||
| Price To Sales | 14.67 X | ||||
| Revenue | 2.69 M | ||||
| EBITDA | (7.9 M) | ||||
| Total Debt | 473.4 K | ||||
| Book Value Per Share | 0.23 X | ||||
| Cash Flow From Operations | (6.1 M) | ||||
| Earnings Per Share | (1.05) X | ||||
| Total Asset | 4.76 M | ||||
| Retained Earnings | (56.8 M) | ||||
About Neuraxis Performance
Assessing Neuraxis' fundamental ratios provides investors with valuable insights into Neuraxis' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Neuraxis is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Neuraxis performance evaluation
Checking the ongoing alerts about Neuraxis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neuraxis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neuraxis is way too risky over 90 days horizon | |
| Neuraxis appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.69 M. Net Loss for the year was (8.24 M) with profit before overhead, payroll, taxes, and interest of 2.84 M. | |
| Neuraxis generates negative cash flow from operations | |
| About 19.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Bear Alert Can NeuroSense Therapeutics Ltd stock beat analyst upgrades - July 2025 Price Swings Weekly High Momentum Picks - moha.gov.vn |
- Analyzing Neuraxis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neuraxis' stock is overvalued or undervalued compared to its peers.
- Examining Neuraxis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neuraxis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neuraxis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neuraxis' stock. These opinions can provide insight into Neuraxis' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Neuraxis Stock Analysis
When running Neuraxis' price analysis, check to measure Neuraxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuraxis is operating at the current time. Most of Neuraxis' value examination focuses on studying past and present price action to predict the probability of Neuraxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuraxis' price. Additionally, you may evaluate how the addition of Neuraxis to your portfolios can decrease your overall portfolio volatility.